down arrow

Anuh Pharma

28
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
172.50
4.95 (2.95%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.87 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 46.23% vs 9.14% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 28.25% vs -52.76% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 66.00% vs 18.38% in Mar 2023

Compare Profit and Loss Results of Anuh Pharma
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
647.00
9,264.00
-8,617.00
-93.02%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
647.00
9,264.00
-8,617.00
-93.02%
Expenditure (Ex Depriciation)
Stock Adjustments
-15.00
-25.00
10.00
40.00%
Raw Materials Consumed
501.00
2,933.00
-2,432.00
-82.92%
Power & Fuel Cost
12.00
70.00
-58.00
-82.86%
Employee Cost
19.00
1,982.00
-1,963.00
-99.04%
Operating Expenses
23.00
143.00
-120.00
-83.92%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
806.00
-797.00
-98.88%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
136.00
-122.00
-89.71%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
571.00
6,939.00
-6,368.00
-91.77%
Operating Profit (PBDIT) excl Other Income
75.00
2,325.00
-2,250.00
-96.77%
Other Income
12.00
266.00
-254.00
-95.49%
Operating Profit (PBDIT)
87.00
2,592.00
-2,505.00
-96.64%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
86.00
2,577.00
-2,491.00
-96.66%
Depreciation
8.00
317.00
-309.00
-97.48%
Profit Before Taxation & Exceptional Items
78.00
2,259.00
-2,181.00
-96.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
78.00
2,259.00
-2,181.00
-96.55%
Provision for Tax
18.00
436.00
-418.00
-95.87%
Profit After Tax
60.00
1,823.00
-1,763.00
-96.71%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
113.00
7,868.00
-7,755.00
-98.56%
Profit Available for appropriations
173.00
9,691.00
-9,518.00
-98.21%
Appropriations
173.00
9,691.00
-9,518.00
-98.21%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
11.98
45.52
-33.54
-73.68%
Profit And Loss - Net Sales
Net Sales 647.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.75 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 46.23% vs 9.14% in Mar 2023

Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 28.25% vs -52.76% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 60.06 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 66.00% vs 18.38% in Mar 2023